OUR NETWORK
We work with a range of companies and organisations across the healthcare ecosystem.
-
Industry Tenants
- Celerion
Celerion is a global leader in early-phase clinical research, specializing in translating science into medicine. They conduct clinical trials for new drugs, focusing on pharmacokinetics, pharmacodynamics, and safety evaluation. Celerion has had a strong presence in Belfast for over 20 years. Celerion will take up residence in iREACH Health, allowing them to expand their activities in Belfast and build upon their existing ties with Queen’s University, Belfast and Belfast City Hospital. Celerion offers expertise in patient recruitment, protocol design, and regulatory guidance. Their work accelerates drug development, helping bring innovative therapies to market efficiently.
- Celerion
- Health and Social Care Partners
Building Regional ​Partnerships
iREACH Health will collaborate with other Belfast Regional City deal projects and existing hubs of innovation. Find out more about some of the other Belfast Regional City Deal/infrastructure projects and how their efforts complement those of iREACH Health below.
-
Momentum One Zero
Momentum One Zero is a global innovation centre led by Queen's University Belfast, focusing on data-driven research and innovation in advanced digital technologies. It aims to address business and societal challenges across sectors such as digital health, agri-food, and cybersecurity. Momentum One Zero and iREACH Health have a shared focus on the use of data-driven innovation to improve healthcare. There is potential for future collaborations between the two centres on AI and machine learning to optimize clinical trials.
- Advanced Manufacturing Innovation Centre (AMIC)
AMIC is an initiative aimed at revitalising Northern Ireland's industrial sector by providing advanced manufacturing facilities and expertise. A key development is the construction of a 10,500m² state-of-the-art Factory of the Future, designed to support innovation and collaboration in manufacturing processes and technologies. The opportunity exists for iREACH and AMI to collaborate on sustainable nanotech applications for medical devices/diagnostics and treatments.
Advanced Manufacturing Innovation Centre | Queen's University Belfast
- Future Medicines Institute
The Future Medicines Institute is a consortium led by Queen's University Belfast, established to drive innovation and productivity in precision medicine within Northern Ireland. There is scope to partner on novel therapeutics identified by FMI, which could be brought to market through clinical trials carried out at iREACH Health.
Future Medicines Institute | Business | Queen's University Belfast
- Centre for Digital Healthcare Technology (CDHT)
The Centre for Digital Healthcare Technology is set to be an exemplary hub for digital technology and associated living labs in areas such as cardiology, diabetes, respiratory, and stroke. It will serve as a collaborative platform for academia, industry, and clinicians to lead research focused on global health challenges, including healthcare costs and healthy ageing. The CDHT and iREACH Health have some overlapping interests in the improvement of healthcare by focusing on data-driven innovations. There is much potential for the two centres to collaborate towards providing new healthcare solutions.